Life Sciences 25
Zoll Medical gave a weaker-than-expected sales forecast; Cubist had its first $100 million quarter.
| LAST | MRKT. CAP | LAST | PCT. | |||
| NO. | WK. | COMPANY | TICKER | (millions) | PRICE | CHANGE |
| 1 | 1 | Covidien Ltd. | COV | $24,959 | $49.96 | 1.9% |
| 2 | 2 | Thermo Fisher Scientific | TMO | $24,591 | $58.80 | 5.1% |
| 3 | 3 | Genzyme Corp. | GENZ | $20,238 | $75.71 | -3.2% |
| 4 | 5 | Biogen Idec | BIIB | $20,173 | $69.50 | 7.5% |
| 5 | 4 | Boston Scientific Corp. | BSX | $18,090 | $12.09 | -13.0% |
| 6 | 6 | Waters Corp. | WAT | $6,738 | $67.31 | 7.4% |
| 7 | 7 | Hologic | HOLX | $6,041 | $23.61 | -1.5% |
| 8 | 8 | Vertex Pharmaceuticals | VRTX | $4,580 | $32.58 | 2.1% |
| 9 | 9 | Charles River Laboratories | CRL | $4,498 | $66.02 | 4.2% |
| 10 | 10 | Millipore Corp. | MIL | $4,034 | $73.22 | 2.6% |
| 11 | 11 | PerkinElmer | PKI | $3,476 | $29.36 | 6.6% |
| 12 | 12 | Inverness Medical Innov. | IMA | $2,456 | $31.65 | 0.9% |
| 13 | 13 | Sepracor | SEPR | $2,261 | $20.98 | 1.0% |
| 14 | 14 | Bruker Corp. | BRKR | $1,959 | $11.99 | 1.3% |
| 15 | 15 | Parexel International Corp. | PRXL | $1,557 | $27.51 | 2.0% |
| 16 | 16 | Alkermes | ALKS | $1,467 | $15.35 | 6.3% |
| 17 | 17 | Haemonetics Corp. | HAE | $1,449 | $56.77 | 5.8% |
| 18 | 18 | Alnylam Pharmaceuticals | ALNY | $1,308 | $32.02 | 2.1% |
| 19 | 19 | Cubist Pharmaceuticals | CBST | $1,215 | $21.54 | 8.0% |
| 20 | 20 | Phase Forward | PFWD | $824 | $19.25 | -2.0% |
| 21 | 22 | Abiomed | ABMD | $665 | $19.96 | 8.3% |
| 22 | 23 | AMAG Pharmaceuticals | AMAG | $639 | $37.58 | 9.0% |
| 23 | 21 | Zoll Medical Corp. | ZOLL | $603 | $28.88 | -11.7% |
| 24 | 24 | Momenta Pharmaceuticals | MNTA | $589 | $16.02 | 5.8% |
| 25 | - | Idenix Pharmaceuticals | IDIX | $470 | $8.34 | 15.8% |
The Boston Globe/Bloomberg Massachusetts Technology and Life Sciences indexes are price-weighted indexes of all technology and life sciences stocks in the state. Listed above are the top companies, ranked by market value, in each sector. Asterisks indicate a stock that has moved five places or more in the last week. For up-to-the-minute rankings and stock prices, visit boston.com/business. 